J. Goldman & Co’s Replimune Group REPL Stock Holding History

J. Goldman & Co’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-67,500	Closed	-$740K	–	594
2024 Q3	$740K	Buy	+67,500	New	+$686K	0.02%	318
2023 Q4	–	Sell	-54,000	Closed	-$924K	–	453
2023 Q3	$924K	Buy	+54,000	New	+$1.06M	0.03%	241

Other funds holding REPL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

J. Goldman & Co's REPL Position: Q1 2026 in Review

J. Goldman & Co sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 15,595 shares — an estimated $119K sold.

J. Goldman & Co first reported a position in REPL in Q4 2022 and held it in 8 quarters. The position peaked at $2.35M in Q4 2022. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

J. Goldman & Co reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
J. Goldman & Co sold 15,595 Replimune Group shares in Q1 2026, an estimated $119K.
J. Goldman & Co first reported a position in Replimune Group in Q4 2022 and held it in 8 quarters.
J. Goldman & Co's Replimune Group position peaked at $2.35M in Q4 2022.
180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.